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Introduction
Ectopic pregnancy is a major cause of maternal mortality
during the first trimester of pregnancy, with a prevalence
estimated in 8 per 1,000 pregnancies [1, 2]. 
Non-tubal ectopic pregnancies are uncommon, account-
ing for about the 5% of all the ectopic pregnancies. The
possible sites of non-tubal ectopic implantation are ce-
sarean scar, cervix, interstitium, cornual region, ovaries,
and other pelvic organs [2-4]. 
Scar ectopic pregnancy is becoming increasing common
all over the globe. It may occur following cesarean section
(i.e. the major risk factor for scar pregnancy, with a risk of
0.15%), myomectomy, endometrial curettage or operative
hysteroscopy [5, 6]. 
Symptoms of ectopic pregnancy are subtle and include
diffuse or localized pelvic pain, shoulder tip pain, vaginal
bleeding, diarrhea, nausea, and vomiting. Nevertheless,
scar pregnancies are often diagnosed in asymptomatic
women [2, 4, 7]. 
A timely diagnosis and therapy of ectopic scar pregnan-
cies allows to avoid severe complications such as uterine
rupture and hemorrhagic shock. Nevertheless, the manage-
ment of this condition is still not standardized [3, 6, 8, 9]. 
Here the authors report three cases of cesarean scar preg-
nancies whose prompt identification and treatment allowed
the prevention of severe complications.
Case Report 
Clinical case 1
A 34-year-old parous patient with a previous history of cae-
sarean section due to fetal distress referred to this University Hos-
pital with a positive pregnancy test (B-hCG: 5,100 mIU/mL), at
six weeks and four days of amenorrhea. The patient, on inspection
and specular examination, presented neither blood loss nor pelvic
pain. At transvaginal ultrasound examination, an anechoic forma-
tion of 18 mm was identified at the isthmic level, in correspon-
dence of the previous cesarean scar. The patient was admitted to
this University Hospital for a suspect of ectopic pregnancy. A re-
peat ultrasound examination, after 48 hours, confirmed the pres-
ence of a gestational camera equipped with a yolk sac. The B-hCG
value was 9,300 mIU/mL. The patient was treated with methotrex-
ate 1 mg/kg i. m. and subsequently the pregnancy was removed
by resectoscopic hysteroscopy. Approximately 24 hours after
surgery, the B-hCG values showed a marked decline. Then, the
patient was discharged (on the same day) and followed-up through
monitoring B-hCG values, until their negativization. An ultra-
sound examination confirmed the resolution of the condition two
weeks later. The histological examination confirmed the presence
of deciduous material. The patient did not experience any type of
medical or surgical complication.
Clinical case 2
A 37-year-old, parous patient with a previous delivery by ce-
sarean section was admitted to this University Hospital due to di-
agnosis of retained abortion at eight gestational weeks. The patient
was asymptomatic and the obstetric visit was negative, without
signs of vaginal blood losses. Transvaginal ultrasound showed a
gestational sac with an average diameter of 29 mm and an embryo
with CRL of 15 mm without cardiac activity. The implant was lo-
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One of the rarest forms of ectopic pregnancy is represented by the implantation of pregnancy on the scar of cesarean section. The im-
plant in the uterine scar tissue exposes the patient to a risk of massive bleeding, uterine rupture, and penetration by the syncytiotrophoblast
into the bladder wall. Currently, there is no consensus on the optimal management of this condition. The medical, surgical, and radio-
interventional approaches are all contemplated. Here the authors report and discuss the diagnosis and treatment of three cases of caesarean
scar pregnancies.
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cated at the uterine isthmus, on the previous cesarean section scar.
Vaginal administration of an ovum of cervidil was undertaken.
After a single administration, the patient began to feel moderate
pelvic pain associated with vaginal bleeding. At that point, the au-
thors proceeded with a surgical evacuation of the uterine cavity.
The patient underwent an ultrasound-guided (with transabdominal
probe) endohysterosuction. The procedure was completed with a
delicate curettage by using a curved curette. The patient did not
experience complications after surgery. The post-intervention B-
hCG assay showed rapidly falling values in the days following
the previous findings.
Clinical case 3
A patient of 22 years, parous, who previously (seven months
before referring at this University Hospital) underwent cesarean
section at the 37th week of pregnancy due to fetal tachycardia. She
referred to thus emergency-obstetric room due to severe pelvic
pain and amenorrhea at eight weeks. Serum B-hCG values were
51,388 mUI/mL. At transvaginal ultrasound, an anechogenic, non-
homogeneous lesion, compatible with a dysmorphic gestational
chamber, in the isthmic region was found. This formation was
protruding across the anterior uterine wall until the posterior blad-
der (Figures 1 and 2).
On the admission day, a diagnostic cystoscopy was performed,
showing a formation which imprinted the bladder cavity between
the two ureteral outlets. At hysteroscopic examination, the authors
found the presence of trophoblastic-like material at the level of
the anterior isthmic region. A pelvic NMR showed the presence
of a rough roundish formation with a diameter of about 55 mm
that was protruding in the left lateral pelvic area from the lateral-
posterior-inferior side of the uterus body. The anterior uterine
wall, at this level, showed a wide parietal interruption, in com-
munication with the endometrial cavity. The lesion appeared as
vacuolar, with numerous convoluted and lacunar vascular forma-
tions. The picture was compatible with an ectopic gestural sac lo-
cated on the scar of the previous caesarean section. Subsequently,
further 2D and 3D ultrasound scans were performed, confirming
the diagnosis. In consideration of the peculiar case (young age
and desire for future pregnancies), the authors decided to treat the
patient by administering the following therapeutic regimen:
methotrexate 1 mg/kg intramuscular injection on days 1, 3, and 5
and levofolinate calcium 0.1 mg/kg intravenously on days 2, 4,
and 6. After therapy, the B-hCG values were equal to 34,186
mIU/mL. The control ultrasound survey showed a slight reduction
in the size of the previously described formation. A reduction of
the vascular gaps surrounding the gestational sac was found at
Doppler colour ultrasonography. Therefore, the authors decided
to proceed with a repeat cycle of MTX plus levofolinate calcium,
during which a severe anemization of the patient occurred, neces-
sitating for blood transfusion. After the second cycle of methotrex-
ate, the B-hCG values were 18,300 mIU/mL and the ultrasound
examination showed a volumetric reduction of the formation,
which appeared of 43 mm in its maximum diameter. At this point,
the authors opted to proceed with surgical treatment. On the same
day, the patient underwent laparotomic surgery. The portion infil-
trated by the trophoblast was removed by curettage. The morphol-
ogy of the uterine wall was successfully reconstructed, in order
to preserve future fertility. The procedure was completed without
major complications. A control MRI performed nine days after
the surgery showed a complete restoration of the uterine anatomy.
A rapid decrease in serum B-hCG was observed, reaching 10.4
mIU/ml at 30 days from surgical treatment. The patient was dis-
charged from hospital on the 11th day after surgery, and an oral
contraceptive therapy was administered for three months.
Discussion
The ectopic implant of an embryo on cesarean scar is an
event whose prevalence is difficult to assess, as only a few
number of case reports are published [9, 10]. Notably, in
the last decade, there has been a substantial increase in the
number of reports in this regard, perhaps due an increase
of pregnancies in women with a history of caesarean sec-
tion [5, 11]. Additionally, in the last two decades, there has
been a considerable increase in pregnancies on hystero-
tomic scar following embryo-transfer, this derived from the
proportional increase in the use of medically assisted fer-
tilization techniques [7-9, 12, 13]. 
Cesarean scar pregnancy was first described in 1978 by
Larsen and Solomon [9], who emphasized its variable clin-
Figure 1. — Transvaginal ultrasound sagittal scan: the scar preg-
nancy, which protruding out of in bladder, shows a rich vascular-
ization at color Doppler examination.
Figure 2. — Transvaginal ultrasound transversal scan:  the scar
pregnancy, which protruding out of in bladder, shows a rich vas-
cularization at color Doppler examination.
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ical presentation. The patient with a scar pregnancy may
have a severe clinical condition (with significant blood loss
associated with intense pelvic pains), or may be completely
asymptomatic. Nevertheless, the authors must stress that it
rarely progresses as asymptomatic up to ten gestational
weeks or more [10, 14]. The diagnosis of cesarean scar
pregnancy is usually made by ultrasound, generally with a
transvaginal probe and color flow Doppler. Rarely, more
invasive methods (such as office hysteroscopy) may be re-
quired [15, 16]. 
A significant factor to keep in mind is the dating of the
pregnancy, referable to the average diameter of the gesta-
tional camera and to the CRL value. The greater the week
of amenorrhea, the value of the average diameter of the
gestational chamber and of the greater CRL, the major
will be infiltration of the trophoblast into the thickness of
the myometrium and, depending on the case, even exter-
nally to it, involving structures outside the uterine serosa
[17]. 
The portion of the uterine wall, involved in the hystero-
tomic access of the previous cesarean section, has a re-
duced thickness compared to a uterus on which surgery
has never been applied [3, 7]. This condition is the deter-
mining factor that produces the high risk of complications
for this given implant location. The pregnancy, in this con-
dition, goes to implant itself on a thinned and fibrotic tis-
sue that borders directly with the inferior bladder wall [8,
9]. Given the infiltrating capacity of the trophoblast and the
functional anatomical features, both dynamic and static of
the hysterotomic scar, they cause the damage produced to
be decidedly dramatic [5, 6]. 
The risk to which patients with this type of implant are
exposed varies, including bleeding, uterine rupture, bladder
infiltration, up to the necessary hysterectomy, with conse-
quent injured function regarding future fertility [18]. Re-
garding the treatment of the case, given the rarity of the
disease, to date there are no guidelines for its optimal man-
agement. We can choose between various therapies: medi-
cal, surgical, and interventional radiology [11, 13, 17-20]. 
Medical treatment involves the use of systemic
methotrexate  and/or ultrasound-guided injection within the
gestational chamber of different agents (methotrexate,
KCL, vasopressin, hyperosmolar glucose, etc.) to interrupt
the pregnancy [21-23]. Methotrexate is the cornerstone of
conservative therapy. 
The surgical approach is designed to mechanically re-
move the pregnancy. In this regard, the rational involves
the excision of the trophoblast from the myometrium via
laparotomy and endoscopy (hysteroscopic resectoscope, la-
paroscopic) [24-26]. In cases where pregnancy has pro-
duced extensive infiltration, hysterectomy and repair of any
bladder damage is also considered if trophoblastic infiltra-
tion has spread outside the uterus [27, 28]. On other hand,
interventional radiology has the considerable advantage of
reduced invasiveness [29]. The mentioned interventions,
especially the surgical ones, can create a reduction in fer-
tility, exposing patients to a greater risk of uterine rupture
in subsequent pregnancies and relapses [12, 28, 29]. These
risks are currently not quantifiable due to the lack of data
present in the literature.
It is important to underline how often, in clinical practice,
single therapeutic methods described are not always deci-
sive. Sometimes it is necessary to refer to more than one
method to obtain a complete resolution of the clinical pic-
ture.
The patients whose clinical course is reported did not pre-
sent any short-term complications. The patient referable to
the second case is currently pregnant.
In conclusion, cesarean scar pregnancy represents a rare
and life-threatening complication of the first trimester of
pregnancy. Clinical history, ultrasound examination and
serum B-hCG measurements are mandatory for a prompt
diagnosis. Additional diagnostic techniques, such as cys-
toscopy, hysteroscopy, and MRI, may be helpful to better
assess the trophoblast’s infiltration (across the uterine wall)
and invasion of surrounding structures (such as bladder). 
A timely intervention, including medical and/or surgical
therapy, is often conclusive. The therapeutic approach varies
according to the clinical scenario, the experience (and skill) of
the operator, and the patient’s desire for future pregnancies.
As current management of cesarean scar pregnancy is not stan-
dardized, future multicentric studies are needed to provide ev-
idence on the best therapeutic approach for this condition.
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